The Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) as an add-on to Metformin or Metformin Plus Sulphonylurea In The Treatment of Type 2 Diabetes Mellitus In Spain
May 1, 2015, 00:00
10.1016/j.jval.2015.03.362
https://www.valueinhealthjournal.com/article/S1098-3015(15)00419-2/fulltext
Title :
The Cost-Effectiveness of Canagliflozin (Cana) Versus Sitagliptin (Sita) as an add-on to Metformin or Metformin Plus Sulphonylurea In The Treatment of Type 2 Diabetes Mellitus In Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00419-2&doi=10.1016/j.jval.2015.03.362
First page :
A62
Section Title :
Diabetes/Endocrine Disorders
Open access? :
No
Section Order :
1464